2022, Number 3
<< Back Next >>
Arch Neurocien 2022; 27 (3)
Protective effects of Buxus hyrcana against memory impairment and oxidative stress in a pentylenetetrazole-kindled epileptic rat model
Azizi V, Allahyari F, Hosseini A
Language: English
References: 41
Page: 16-22
PDF size: 205.12 Kb.
ABSTRACT
Introduction: Pentylenetetrazole (PTZ) is a chemical substance that is largely used for the induction of
seizure and epilepsy in the animal model, and it can also disrupt free radicals balance and cause oxidative
stress in the body with a negative impact on memory and learning. In this study, the medicinal plant Buxus
hyrcana was used to evaluate its effect on oxidative stress and memory deficit caused by ptz in rats.
Methods: Twenty-four rats were randomly allocated in 4 groups: control negative under treatment with
PTZ (sub-threshold dose 35 mg/kg for one month), control positive under treatment with phenobarbital
(PB-30 mg/kg), and two PTZ groups under treatment with B. hyrcana extract (BHE-300, and -600 mg/
kg). Standard passive avoidance test was used to evaluate retention and recall (evaluation of memory
and learning). After behavioral evaluation, the rats were anesthetized, their brains were removed,
and brain homogenates were prepared; oxidative stress was evaluated using specified methods.
Results: Step-through latency according to the passive avoidance test was greater in the bhe receiving
group than in the ptz group (p‹0.001). In addition, brain lipid peroxidation malondialdehyde (MDA)
and nitric oxide (NO) level in the bhe-treated group was significantly lower (p‹0.001), and the reduced
glutathione (GSH) levels were significantly greater versus PTZ group (p‹0.001).
Discussion: Our results showed that bhe could prevent memory deficit caused by PTZ-induced kindling
and this could be attributed to amelioration in oxidative stress damage through antioxidant mechanism.
REFERENCES
Katyayan A, Diaz-Medina G. Epilepsy: Epileptic Syndromes andTreatment. Neurol Clin. 2021;39(3):779-795. doi:10.1016/j.ncl.2021.04.002
Suleymanova EM. Behavioral comorbidities of epilepsy andneuroinflammation: Evidence from experimental and clinicalstudies. Epilepsy Behav. 2021; 117:107869. doi:10.1016/j.yebeh.2021.107869
Fattorusso A, Matricardi S, Mencaroni E, et al. ThePharmacoresistant Epilepsy: An Overview on Existant andNew Emerging Therapies. Front Neurol. 2021; 12:674483.doi:10.3389/fneur.2021.674483
Holmes GL. Cognitive impairment in epilepsy: the role ofnetwork abnormalities. Epileptic Disord. 2015; 17(2):101-116.doi:10.1684/epd.2015.0739
Waldbaum S, Patel M. Mitochondria, oxidative stress, andtemporal lobe epilepsy. Epilepsy research. 2010; 88(1):23-45.
Costello DJ, Delanty N. Oxidative injury in epilepsy: potential forantioxidant therapy? Expert Rev Neurother. 2004; 4(3):541-553.
Stadtman ER. Protein oxidation in aging and age‐relateddiseases. Ann N Y Acad Sci. 2001; 928(1):22-38.
Migliore L, Fontana I, Colognato R, Coppede F, SicilianoG, Murri L. Searching for the role and the most suitablebiomarkers of oxidative stress in Alzheimer's disease and inother neurodegenerative diseases. Neurobiol Aging. 2005;26(5):587-595.
Bonda DJ, Lee H-P, Lee H-g, et al. Novel therapeutics forAlzheimer's disease: an update. Curr Opin Drug Discov Dev.2010; 13(2):235.
Ashrafi MR, Shams S, Nouri M, et al. A probable causative factorfor an old problem: selenium and glutathione peroxidase appearto play important roles in epilepsy pathogenesis. Epilepsia.2007; 48(9):1750-1755.
Shin E-J, Jeong JH, Chung YH, et al. Role of oxidative stress inepileptic seizures. Neurochem Int. 2011; 59(2):122-137.
Kumar A, Lalitha S, Mishra J. Possible nitric oxide mechanismin the protective effect of hesperidin against pentylenetetrazole(PTZ)-induced kindling and associated cognitive dysfunction inmice. Epilepsy Behav. 2013; 29(1):103-111. doi:10.1016/j.yebeh.2013.06.007
Saha L, Chakrabarti A. Understanding the anti-kindling roleand its mechanism of Resveratrol in Pentylenetetrazole inducedkindlingin a rat model. Pharmacol Biochem Behav. 2014;120:57-64. doi:10.1016/j.pbb.2014.01.010
Kowski AB, Weissinger F, Gaus V, Fidzinski P, Losch F, HoltkampM. Specific adverse effects of antiepileptic drugs--A true-to-lifemonotherapy study. Epilepsy Behav. 2016; 54:150-157.doi:10.1016/j.yebeh.2015.11.009
Pahuja M, Mehla J, Kumar Gupta Y. Anticonvulsant andantioxidative activity of hydroalcoholic extract of tuber ofOrchis mascula in pentylenetetrazole and maximal electroshockinduced seizures in rats. J Ethnopharmacol. 2012; 142(1):23-27. doi:10.1016/j.jep.2012.04.006
Babar ZU, Ata A, Meshkatalsadat MH. New bioactive steroidalalkaloids from Buxus hyrcana. Steroids. 2006; 71(13-14):1045-1051. doi:10.1016/j.steroids.2006.09.002
Choudhary MI, Shahnaz S, Parveen S, et al. New cholinesteraseinhibitingtriterpenoid alkaloids from Buxus hyrcana.Chem Biodivers. 2006;3(9):1039-1052. doi:10.1002/cbdv.200690102
Esmaeili S, Naghibi F, Mosaddegh M, Sahranavard S, GhafariS, Abdullah NR. Screening of antiplasmodial properties amongsome traditionally used Iranian plants. J Ethnopharmacol.2009;121(3):400-404. doi:10.1016/j.jep.2008.10.041
Ata A, Iverson CD, Kalhari KS, et al. Triterpenoidal alkaloids fromBuxus hyrcana and their enzyme inhibitory, anti-fungal and antileishmanialactivities. Phytochemistry. 2010; 71(14-15):1780-1786. doi:10.1016/j.phytochem.2010.06.017
Ebrahimzadeh MA, Nabavi SM, Nabavi SF, Bahramian F,Bekhradnia AR. Antioxidant and free radical scavenging activityof H. officinalis L. var. angustifolius, V. odorata, B. hyrcana andC. speciosum. Pak J Pharm Sci. 2010; 23(1):29-34.
Mesaik MA, Halim SA, Ul-Haq Z, et al. Immunosuppressiveactivity of buxidin and E-buxenone from Buxushyrcana. Chem Biol Drug Des. 2010; 75(3):310-317.doi:10.1111/j.1747-0285.2009.00906.x
22.Azizi V, Allahyari F, Hosseini A. The antiepileptic andneuroprotective effect of the Buxus hyrcana Pojark hydroethanolicextract against the pentylentetrazol induced model of the seizuresin the male rats. Int J Neurosci. 2018; 128(10):913-919. doi:10.1080/00207454.2018.1443925
Pahuja M, Mehla J, Reeta KH, Tripathi M, Gupta YK. Effect ofAnacyclus pyrethrum on pentylenetetrazole-induced kindling,spatial memory, oxidative stress and rho-kinase II expression inmice. Neurochem Res. 2013; 38(3):547-556. doi:10.1007/s11064-012-0947-2
Gomar A, Hosseini A, Mirazi N. Preventive effect of Rubusfruticosus on learning and memory impairment in an experimentalmodel of diabetic neuropathy in male rats. PharmaNutrition.2014;2(4):155-160.
Beutler E, Duron O, Kelly BM. Improved method for thedetermination of blood glutathione. J Lab Clin Med.1963;61:882-888.
Biswas D, Banerjee M, Sen G, et al. Mechanism of erythrocytedeath in human population exposed to arsenic throughdrinking water. Toxicol Appl Pharmacol. 2008; 230(1):57-66.doi:10.1016/j.taap.2008.02.003
Schulz K, Kerber S, Kelm M. Reevaluation of the Griess methodfor determining NO/NO2- in aqueous and protein-containingsamples. Nitric Oxide Biol Chem. 1999; 3(3):225-234.doi:10.1006/niox.1999.0226
Choudhary KM, Mishra A, Poroikov VV, Goel RK. Ameliorativeeffect of Curcumin on seizure severity, depression like behavior,learning and memory deficit in post-pentylenetetrazole-kindledmice. Eur J Pharmacol. 2013; 704(1-3):33-40.
Mariani E, Polidori M, Cherubini A, Mecocci P. Oxidative stressin brain aging, neurodegenerative and vascular diseases: anoverview. J Chromatogr B. 2005; 827(1):65-75.
Perry G, Nunomura A, Hirai K, et al. Is oxidative damage thefundamental pathogenic mechanism of Alzheimer’s and otherneurodegenerative diseases? Free Radic Biol Med. 2002;33(11):1475-1479.
Sudha K, Rao AV, Rao A. Oxidative stress and antioxidants inepilepsy. Clin Chim Acta. 2001; 303(1-2):19-24.
Zhao R-r, Xu X-c, Xu F, et al. Metformin protects against seizures,learning and memory impairments and oxidative damageinduced by pentylenetetrazole-induced kindling in mice. BiochemBiophys Res Commun. 2014; 448(4):414-417.
Rauca C, Zerbe R, Jantze H. Formation of free hydroxyl radicalsafter pentylenetetrazol-induced seizure and kindling. Brainresearch. 1999; 847(2):347-351.
Nassiri-Asl M, Moghbelinejad S, Abbasi E, et al. Effects ofquercetin on oxidative stress and memory retrieval in kindledrats. Epilepsy Behav. 2013; 28(2):151-155.
Barnham KJ, Masters CL, Bush AI. Neurodegenerative diseasesand oxidative stress. Nat Rev Drug Discov. 2004; 3(3):205-214.doi:10.1038/nrd1330
Stewart VC, Heales SJ. Nitric oxide-induced mitochondrialdysfunction: implications for neurodegeneration. FreeRadic Biol Med. 2003; 34(3):287-303. doi:10.1016/s0891-5849(02)01327-8
Murashima YL, Yoshii M, Suzuki J. Ictogenesis andepileptogenesis in EL mice. Epilepsia. 2002; 43 Suppl 5:130-135. doi:10.1046/j.1528-1157.43.s.5.35.x
Bors W, Heller W, Michel C, Saran M. Flavonoids as antioxidants:Determination of radical-scavenging efficiencies. Meth Enzymol.Vol 186: Elsevier; 1990:343-355.
Ishige K, Schubert D, Sagara Y. Flavonoids protect neuronal cellsfrom oxidative stress by three distinct mechanisms. Free RadicBiol Med. 2001; 30(4):433-446.
Cárdenas-Rodríguez N, Coballase-Urrutia E, Pérez-CruzC, et al. Relevance of the glutathione system in temporallobe epilepsy: evidence in human and experimental models.Oxid Med Cell Longev. 2014; 2014:759293-759293.doi:10.1155/2014/759293
Wollenweber E, Rustaiyan A. Exudate flavonoids in three persianasteraceae species. Biochem Syst Ecol. 1991; 19(8):673-675.doi:10.1016/0305-1978(91)90084-D